|
Efficacy, Safety, LDL Cholesterol Lowering, and 10-Year ASCVD Risk Reduction: Alirocumab and Evolocumab in Addition to Maximal Tolerated LDL Lowering |
|
|
|
Title: |
Efficacy, Safety, LDL Cholesterol Lowering, and 10-Year ASCVD Risk Reduction: Alirocumab and Evolocumab in Addition to Maximal Tolerated LDL Lowering |
Author: |
D'Souza, Kenneth Rothschild, Matan Jetty, Vybhav Anaba, Uzoma Min, Sarah Goldenberg, Naila Wang, Ping Glueck, Charles |
Appeared in: |
Journal of clinical lipidology |
Paging: |
Volume 11 (2017) nr. 3 pages 1 p. |
Year: |
2017 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|